Dr. Anushree Chatterjee is an Assistant Professor of Chemical and Biological Engineering at University of Colorado Boulder. Prior to joining UC Boulder, she was a postdoctoral research fellow at the Theoretical Biology and Biophysics group at Los Alamos National Laboratory studying gene regulation of hepatitis C virus. She completed her PhD in Chemical engineering at the University of Minnesota on understanding molecular mechanisms of antibiotic resistance transfer in clinical superbugs.
The overarching goal of her research is to develop strategies for rationally engineering next-generation smart antimicrobials that can eliminate multi-drug resistant superbugs, with the ultimate goal of creating therapies that can evade evolution of drug-resistance in microbes. To achieve this goal her lab uses a combination of interdisciplinary approaches including synthetic biology, systems biology, and nanoengineering to design smart therapeutics. Anushree’s research has been featured by academic and federal institutions such as the Material Research Society, Faculty of 1000, and the National Science Foundation, as well as popular national and international media outlets. Anushree has received the DARPA Young Faculty Award, New Inventor of the Year award, the prestigious William M. keck Foundation grant award. She was recently named as one of the highly-prolific authors by ACS Infectious Diseases. She has also co-founded a Biotech startup company.